- Raleigh, North Carolina, United States
Company SummaryOxiPath Health was positioned to sell a new pyridoxamine supplement for diabetics. Pyridoxamine is a derivative of vitamin B6 that inhibits oxidative stress-induced reactive molecules that are known to contribute to diabetic complications. OxiPath will also acquire a proven and patented method of pyridoxamine production that is significantly more cost effective than other methods enabling the Company to become the primary supplier to the supplement industry.New pyridoxamine-formulated supplement scientifically proven to interfere with oxidative stress that contributes to the development of diabetic complications